Thankfully, medical advancements have resulted in minimally invasive procedures for many back problems. Spinal stenosis, for example, can be treated using minimally invasive laminectomy, where parts of the vertebra are removed to relieve pressure on the nerves. “Some patients suffering from herniated disc can also be treated through disc nucleoplasty,” Dr Tow explains, “where a special radio-frequency ablation needle is used to decrease the internal pressure in the disc, decreasing the impingement on the nerves and spinal cord.” In the case of disc nucleoplasty, it can even be just as fast as the epidural injection.
If you suffer from plantar fasciitis, you might think perhaps you should rest your feet, but it’s actually better for you to keep on the move. Plantar fasciitis affects the band of tissue connecting your heel bone to your toes, and can cause stabbing pains when walking. A treatment for it is to keep moving, but make sure you don’t overdo it. Keep your mileage and speed down if you begin experiencing pain, and place an ice pack under your foot for 15 minutes after you’ve finished walking. An alternative is to roll a frozen bottle of water under your foot for 10 to 15 minutes instead. Adding support to your foot can also help, so using an insole in your shoe or wrapping your foot with athletic tape is also recommended. To find out more about this, read this guide to Walking With Plantar Fasciitis .
Drug compounding centers are not regulated by the high standards that drug producers must meet. Most compounding centers are regulated by state agencies and not by the stricter FDA rules that are applied to drug producers. This current outbreak of fungal meningitis, joint infections, and other infections such as epidural abscesses related to products used to treat patients is likely to change this "oversight or regulation" situation. Currently, several high-ranking politicians are demanding stricter regulations be set up for drug-compounding companies. The FDA commissioner, the NECC cofounder, and the director of the Massachusetts Board of Registration in Pharmacy are scheduled to meet with a congressional panel on Nov. 14, 2012. Confidence in compounded drugs can be brought back to the many doctors and patients who need to use them only if such incidences of contaminated drugs from compounding centers are substantially reduced or eliminated.